NYSE · Drug Manufacturers - Specialty & Generic

PRGO (PRGO) Stock

$12.84 +2.39% NYSE: PRGO Healthcare

Valuation

MetricValue
Price$12.84
Market Cap$1.78B
P/E Ratio-1.06
P/B Ratio0.52
P/S Ratio0.35
EPS (TTM)$-10.29
52-Week High$28.44
52-Week Low$9.23
Dividend Yield10.86%

Financials & Margins

MetricValue
ROE-48.54%
ROA-16.70%
ROCE11.69%
Gross Margin8.06%
Operating Margin8.06%
Net Margin-43.50%
Debt/Equity1.52
Current Ratio2.76

Annual Financials (USD)

Metric20212022202320242025
Revenue$4.1B$4.5B$4.7B$4.4B$4.3B
Operating Profit$410.0M$79.0M$152.0M$113.0M$343.0M
Net Profit$-69.0M$-141.0M$-13.0M$-172.0M$-1.4B
EPS$-0.98$-0.97$-0.09$-1.25$-10.29
Op Margin9.9%1.8%3.3%2.6%8.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$10.4B$11.0B$10.8B$9.6B$8.5B
Total Liabilities$5.3B$6.2B$6.0B$5.3B$5.6B
Cash$1.9B$601.0M$751.0M$559.0M$532.0M
Borrowings$3.7B$4.3B$4.1B$3.6B$4.0B

Latest News

Perrigo Announces Appointment of Two New Independent Directors to Board PR Newswire · Jun 30, 2026 Stryker (SYK) Moves 5.3% Higher: Will This Strength Last? Zacks · Jun 29, 2026 FDA Seeks Updated Labeling for Testosterone Therapies MT Newswires · Jun 18, 2026 Jim Cramer on Perrigo Comapny: “This Is a Value Trap” Insider Monkey · Jun 17, 2026 Perrigo Leadership Shakeup Puts Governance And Long Term Strategy In Focus Simply Wall St. · Jun 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$156.0M$307.0M$406.0M$363.0M$239.0M
Investing Cash Flow$1.1B$-2.1B$-179.0M$-39.0M$-169.0M
Financing Cash Flow$-18.0M$-20.0M$-7.0M$-21.0M$-26.0M
Net Cash Flow$1.2B$-1.3B$151.0M$-192.0M$-27.0M
Free Cash Flow$4.0M$211.0M$304.0M$245.0M$145.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA7.27
FCF Yield7.29%
Quick Ratio1.59
Interest Coverage2.10
Return 1Y-61.86%
Return 3Y-67.28%
Return 5Y-74.03%

Ownership

Insiders Held0.40%
Institutions Held116.80%
Institutions Float Held117.27%
Institutional HolderSharesReport Date
Blackrock Inc.17,120,0842026-03-31
Price (T.Rowe) Associates Inc13,376,7762026-03-31
Neuberger Berman Group, LLC10,460,0802026-03-31
Vanguard Portfolio Management LLC8,141,9192026-03-31
Fuller & Thaler Asset Management Inc.7,662,8832026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATEC $9.65 +3.54% -8.57 $1.48B 0.00%
BHCBausch Health Companies Inc. $4.58 +3.27% -1.38 $1.71B 0.00%
FOLDAmicus Therapeutics Inc $14.49 +0.00% -161.00 $4.55B 0.00%
HCMHUTCHMED (China) Limited $11.25 +0.99% 4.28 $1.96B 0.00%
HTFL $28.82 +5.99% -101.97 $2.49B 0.00%

About PRGO

PRGO is led by CEO Patrick Lockwood-Taylor, publicly traded since 1991.

PRGO stock trades at $12.84 with a market capitalization of $1.78B. The stock is valued at a price-to-earnings (P/E) ratio of -1.06, price-to-book of 0.52, price-to-sales of 0.35. Over the past 52 weeks the stock has ranged between $9.23 and $28.44, and currently trades 54.9% below its 52-week high. It pays a dividend yielding 10.86%.

On profitability, PRGO generates a return on equity (ROE) of -48.54%, return on capital employed of 11.69%, an operating margin of 8.06%, a net profit margin of -43.50%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides